Switch to
Predicate | Object |
---|---|
rdf:type | |
lifeskim:mentions | |
pubmed:issue |
4
|
pubmed:dateCreated |
1995-4-6
|
pubmed:abstractText |
Blood group antigen-related oligosaccharides have been implicated in growth regulation, cell mobility control and adhesion; we are therefore interested in the localization of receptors for these oligosaccharides in tumour cells. Labelled neoglycoconjugates that carry synthetic sugar structures are suitable tools to determine: whether such binding sites are present in human lung cancer; whether structural alterations of the glycoligand part will affect extent of binding; and whether cell type-associated alterations can be detected. Sections from 121 cases of lung cancer, representing small cell and non-small cell lung carcinoma, mesothelioma and metastases from extrapulmonary primary carcinomas were used to study the binding of nine synthetic AH- and Le-related oligosaccharides. Probes with fucose-alpha 1-3/4-N-acetylglucosamine-beta 1-R, an A-like disaccharide and 3'-sulfated galactose as ligand appear to bind less well to small cell than to non-small cell lung cancer cases, whereas Lec-disaccharide distinguishes mesothelioma from metastatic carcinoma. The latter ligand, A-like disaccharide and H (type III)-like trisaccharide exhibit evident cell type-associated differences in extent of binding. Thus, tailor-made neoglycoconjugates constitute a promising class of histopathological tools that warrants further study.
|
pubmed:language |
eng
|
pubmed:journal | |
pubmed:citationSubset |
IM
|
pubmed:chemical |
http://linkedlifedata.com/resource/pubmed/chemical/Antigens, Neoplasm,
http://linkedlifedata.com/resource/pubmed/chemical/Galactosides,
http://linkedlifedata.com/resource/pubmed/chemical/Isoantigens,
http://linkedlifedata.com/resource/pubmed/chemical/Oligosaccharides,
http://linkedlifedata.com/resource/pubmed/chemical/Receptors, Antigen,
http://linkedlifedata.com/resource/pubmed/chemical/beta-galactoside
|
pubmed:status |
MEDLINE
|
pubmed:month |
Aug
|
pubmed:issn |
0282-0080
|
pubmed:author | |
pubmed:issnType |
Print
|
pubmed:volume |
11
|
pubmed:owner |
NLM
|
pubmed:authorsComplete |
Y
|
pubmed:pagination |
339-44
|
pubmed:dateRevised |
2006-11-15
|
pubmed:meshHeading |
pubmed-meshheading:7873930-Antigens, Neoplasm,
pubmed-meshheading:7873930-Carbohydrate Sequence,
pubmed-meshheading:7873930-Diagnosis, Differential,
pubmed-meshheading:7873930-Galactosides,
pubmed-meshheading:7873930-Glycosylation,
pubmed-meshheading:7873930-Humans,
pubmed-meshheading:7873930-Isoantigens,
pubmed-meshheading:7873930-Lung Neoplasms,
pubmed-meshheading:7873930-Molecular Sequence Data,
pubmed-meshheading:7873930-Oligosaccharides,
pubmed-meshheading:7873930-Receptors, Antigen
|
pubmed:year |
1994
|
pubmed:articleTitle |
Cell type-dependent alterations of binding of synthetic blood group antigen-related oligosaccharides in lung cancer.
|
pubmed:affiliation |
Department of Pathology, Thoraxklinik, Heidelberg, FRG.
|
pubmed:publicationType |
Journal Article,
Comparative Study,
Research Support, Non-U.S. Gov't
|